The UK Food Standards Agency (FSA) has issued a letter to stakeholders to clarify the potential impact of the proposed UK-EU Sanitary and Phytosanitary (SPS) Agreement on novel foods, including CBD products. Following enquiries from retailers about what a future SPS agreement could mean for the CBD market, the FSA has confirmed that its current […]
Read More
The CIC is closely monitoring the anticipated publication of the Advisory Council on the Misuse of Drugs (ACMD) report on medical cannabis, which has been expected to publish this summer and has yet to be released. The CIC made a submission to the call for evidence back in autumn 2025. The report is expected to examine the evidence […]
Read More
The CIC welcomes the appointment of Andy Burnham as Prime Minister and Yvette Cooper as Secretary of State for Health & Social Care. We are optimistic that the new government presents an opportunity for constructive, evidence-led engagement on the future of medical cannabis in the UK. The UK’s medical cannabis sector has matured significantly since […]
Read More
New FOI data has revealed that pharmacist independent prescribers are responsible for the majority of cannabis-based medicinal product (CBPM) prescriptions issued in the UK. The analysis found that pharmacist independent prescribers accounted for 955,471 prescription items, representing 61.9% of the 1.54 million CBPM items prescribed between January 2019 and May 2025. Doctors accounted for 35.8% […]
Read More
The latest Care Quality Commission (CQC) annual update on controlled drugs offers another encouraging snapshot of the continued development of the UK’s medical cannabis sector. Some of key takeaways include: A 2.3x increase in cannabis-based products for medicinal use (CBPMs) prescribed in the year to 31 March 2025, demonstrating continued growth in patient access. 63% […]
Read More
Nominations are now open for the Cannabis Industry Awards 2026, recognising individuals who have made outstanding contributions to the UK’s cannabis sector. The event is kindly presented by Aurora Medicine and MediStack. Hosted by the Cannabis Industry Council, the Cannabis Industry Awards celebrate excellence, leadership and innovation across the UK’s legal cannabis industry. Winners will […]
Read More
The CIC is proud to represent more than 100 member organisations spanning the UK’s cannabis ecosystem, including manufacturers, distributors, clinics, pharmacies, patient organisations, research bodies, professional services, and CBD and industrial hemp businesses. Together, our members account for a significant proportion of prescribing activity, product supply and regulatory engagement across the sector. By bringing industry […]
Read More
As the leading trade body voice of the UK’s cannabis industry, the Cannabis Industry Council (CIC) exists to professionalise the sector, influence policy, and create a credible, collaborative platform for businesses shaping the future of cannabis in the UK and globally. Our sponsorship and advertising partners play a vital role in supporting this mission. Through […]
Read More
LONDON, UNITED KINGDOM – Tuesday, 2nd June, 2026 – The Cannabis Industry Council “(CIC)”, the leading membership organisation representing the UK’s regulated cannabis sector, announced today the appointment of David Skinner and Dr Chris Hayes as Non-Executive Directors to its Board, voted in by CIC members in e-ballot. The appointment reinforces the CIC’s commitment to […]
Read More
Activities under Pillar 3, the CIC’s Education, Awareness & Standards pillar, are progressing this year, with a growing focus on improving patient education, awareness, and the development of meaningful industry standards across the UK medical cannabis industry. Following the release of the CIC’s “Travelling with Medical Cannabis” guide earlier this year, the pillar’s Education Taskforce […]
Read More